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11 Abstract
12 Introduction: Hypomelanosis of Ito is a rare neurocutaneous disorder, characterized by streaks and swirls of
13 hypopigmentation following the lines of Blaschko that may be associated to systemic abnormalities involving the
14 central nervous system and musculoskeletal system. Despite the preponderance of reported sporadic hypomelanosis of
15 Ito, few reports of familial hypomelanosis of Ito have been described.
16 Case presentation: A 6-month-old Caucasian girl presented with unilateral areas of hypomelanosis distributed on the
17 left half of her body and her father presented with similar mosaic hypopigmented lesions on his upper chest. Whereas
18 both blood karyotypes obtained from peripheral lymphocyte cultures were normal, a 16% trisomy 2 mosaicism was
19 found in cultured skinfibroblasts derived from a hypopigmented skin area of her father.
20 Conclusions: Familial cases of hypomelanosis of Ito are very rare and can occur in patients without systemic involvement.
21 Hypomelanosis of Ito constitutes a non-specific diagnostic definition including different clinical entities with a
22 wide phenotypic variability, either sporadic or familial. Unfortunately, a large number of cases remain misdiagnosed
23 due to both diagnostic challenges and controversial issues on cutaneous biopsies in the pediatric population.
24 Keywords: Hypomelanosis of Ito, Trisomy 2 mosaicism, Familial hypomelanosis of Ito, Neurocutaneous disorder,
25
Blaschko lines
26 Introduction
27 Hypomelanosis of Ito (HMI) is a neurocutaneous pheno-
28 type characterized by hypopigmented anomalies along the
29 Blaschko lines, with systemic abnormalities involving the
30 central nervous and muscle-skeletal systems. It was firstly
31 described as incontinentia pigmenti achromians in 1952
32 [1]. Because of its complex diagnosis the precise prevalence
33 is difficult to estimate, but it has been calculated that HMI
34 is present in 1 in 3,000 to 1 in 10,000 children [2]. Both
35 sexes are affected with an approximately 2:1 female pre-
36 ponderance [3]. The clinical manifestations vary from small
37 hypopigmented areas to hemisomatic large hypopigmented
38 whorls. The streaks can be unilateral or bilateral and, gen-
39 erally, they follow the lines of Blaschko. Lesions appear
40 within the first year of life in about three quarter of the pa-
41 tients. The different pigmented skin areas correspond to
42the distribution of the two distinct cell clones with dif-
43ferent pigment potential in single individuals. The extra-
44cutaneous manifestations (such as scoliosis, vertebral
45anomalies and craniofacial malformations) involve the
46central nervous system and muscle-skeletal system in
4733 to 94% of the cases, respectively [4]. However, cardiac,
48genitourinary and ophthalmic anomalies have been de-
49scribed. These extra-cutaneous manifestations probably
50do not reflect the variability of one single disorder, but can
51be due to the presence of different genetic defects. Usually
52HMI is considered a sporadic disorder, but dominant and
53recessive (including X-linked) inheritance has also been
54reported [1-3]. HMI can be due to gametic half chromatid
55or somatic mutations, or to chromosomal mosaicisms [5],
56which have been demonstrated in some of the affected
57patients by means of skin biopsies. Moreover, an associ-
58ation between HMI and ring chromosome 20, trisomy
59of chromosome 13, and other cytogenetic abnormalities
60have been described [2]. In this paper we present the
61clinical and cytogenetic characterization of a familial
62case of HMI (father and daughter), and we analyze all
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63 the familial cases of HMI reported in scientific literature.
64 The criteria set forth by Ruiz-Maldonado et al. for the
65 diagnosis of HMI were used [6]. Chromosomes were proc-
66 essed by standard GTG- and/or QFQ-banding techniques
67 and analyzed at a resolution of 400 bands for a haploid set
68 [International System for Human Cytogenetic Nomencla-
69 ture (ISCN), 2013] for both the peripheral blood and fi-
70 broblasts from skin biopsy. A minimum of 100 metaphase
71 spreads from two separate cultures for the peripheral
72 blood, and six for the skin biopsy, were examined.
73 Case presentation
74 A 6-month-old Caucasian girl presented to our department
75 for the evaluation of right hemisomatic hypopigmented
76 streaks of the trunk and of one leg noted at 3-months-
77 old after sun exposure. At no time were vesicobullous,
78 lichenoid, or verrucous lesions observed and on clinical
79 examination she did not show any other extra-cutaneous
80 manifestations. Her growth and development since birth
81 were within normal limits. Her physical examination was
82 unremarkable, except for the presence of hypopigmented
83 areas on the right leg and on the trunk and back in a
84 pattern which did not cross the midline (FigureF1 1). Re-
85 garding the family history and examination of family mem-
86 bers, similar hypomelanotic lesions had been present in
87her father since birth, but no other peculiar signs or symp-
88toms were present in her genealogic tree. Her mother, 39-
89years-old at the time of delivery, was in excellent health.
90Moreover, there was no family history of congenital ner-
91vous or systemic abnormalities. The karyotypic analysis of
92the peripheral blood cultures of our patient and her father
93did not reveal any chromosomal anomaly. The karyotypic
94analysis from fibroblast cultures obtained from a skin
95biopsy of the hypopigmented area of the father of our
96patient showed the presence of a trisomy 2 cell line in a
9716% mosaic with a normal cell line (karyotype: mos47,
98XY,+2(15)/46,XY(90); Figure F22). Her parents decided not
99to authorize the excisional biopsy on their daughter and
100the fibroblast karyotypic analysis could not be performed.
101Discussion
102To the best of our knowledge only 15 reports of famil-
103ial HMI have been described in the current literature
104(Table T11). HMI may present in both sexes and domin-
105ant, recessive and X-linked inheritances have been reported
106[1-3] as chromosomal aberrations of this rare disorder.
107HMI may also be transmitted from parent to child with
108variable presentation and expressivity (Table 1). In the
109HMI family described by Sacrez et al. and Grosshans et al.
110[7,8], the mother and her three daughters were all affected.
Figure 1 Clinical features of two probands. (a and b) right hemisomatic hypopigmented streaks of the trunk and of one leg in our patient;
(c and d) small hypopigmented areas on the upper chest in her father.
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111 The daughters showed clinical and histopathological cuta-
112 neous changes typical of HMI, marked psychomotor re-
113 tardation, strabismus, hypodontia and skeletal dysplasia.
114 The mother had only non-specific hypopigmented areas.
115 The inheritance in this family with four female individ-
116 uals suggested an X-linked dominant trait. Cram and
117 Fukuyama described HMI in a child, his mother and his
118 maternal grandfather [9]. Patrizi et al. [10] reported two
119 siblings, a boy and a girl, with typical HMI and neurological
120 symptoms. The mother had typical pigmentary abnormal-
121 ities without neurological defects [10]. Vormittag et al. [3]
122 reported a family with an affected mother and daughter
123 that was probably consistent with HMI. The mother
124 showed hypopigmentation, eye anomalies, epileptic sei-
125 zures and skeletal abnormalities. Her daughter displayed
126 hypopigmentation following the lines of Blaschko and eye
127 anomalies [3]. A pair of monozygotic and a pair of dizygotic
128 twins with a patchy and linear hypopigmentation and
129 autism were reported by Zappella [11]. He found that,
130 in the family of the dizygotic twins, the father had three
131 small depigmented spots and the mother had two depig-
132 mented streaks [11]. Our familial case showed only
133 skin involvement without systemic alterations. Regard-
134 ing the association between HMI and systemic features,
135 Nehal et al. suggested that the incidence of associated ab-
136 normal features described in previous studies is overstated,
137 and that pigmentary anomalies along the lines of Blaschko
138 are associated with abnormal systemic features less often
139 than previously reported [12]. In their retrospective case
140 series the authors detected that extra-cutaneous abnormal
141 features were present in 16 (30%) of 54 children with
142aberrant pigmentation along the lines of Blaschko and
143in particular in only 9 (33%) of 27 with hypomelanosis
144of Ito. Notably, however, the systemic manifestations
145can be related to the level of mosaicism in the affected
146organs. Although we cannot provide evidence of a com-
147mon origin of the HMI in the father and his daughter
148in our case report, we postulate that the HMI in the daugh-
149ter can be due to a rescue of the trisomy 2 zygote. When
150this is considered, the normal neurologic and systemic de-
151velopment of the young proband allows us to clinically
152exclude the effects of uniparental disomy (UPD) [13]. It
153is known that cases of HMI not only show considerable
154phenotypic variability, but also genotypic variability, with
155a wide spectrum of chromosomal mosaicisms. A tri-
156somy 2 mosaicism as described in our case report has
157been reported only once in HMI to the best of our
158knowledge [14]. The authors described a newborn girl
159with classic skin findings of HMI with true (postnatal
160confirmation) trisomy 2 mosaicism. Complete trisomy
1612 usually results in first trimester pregnancy losses; tri-
162somy 2 is not fatal only when present in a mosaic style.
163Cases of infants born live with trisomy 2 mosaicism
164previously described are characterized by intrauterine
165growth retardation and multiple congenital systemic
166anomalies [15]. Due to the finding of different chromo-
167somal aberrations, it has been suggested that HMI
168does not represent a single condition, but rather a
169non-specific manifestation of chromosomal mosaicism
170[4]. Our clinical observations suggest that HMI consti-
171tutes a general diagnostic definition that can include
172different sporadic and/or familial clinical phenotypes
Figure 2 Karyotypic analysis from fibroblast cultures obtained from a skin biopsy of the hypopigmented area showing trisomy 2.
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t1:1 Table 1 Reported case of familial hypomelanosis of Ito (HMI)
t1:2 Citation Year Authors HMI affected Members Systemic features Karyotype
t1:3 [16] 1963 Masumizu Parents None Not performed
t1:4 [17] 1969 Piñol et al. Mother and her daughter Myopia, chorioretinal and retinal pigment
epithelium atrophy in the right eye
Not performed
t1:5 [7] 1970 Sacrez et al. Mother and three daughters Congenital encephalopathy Normal (peripheral lymphocytes)
t1:6 (performed only in one
daughter)
t1:7 [8] 1971 Grosshans et al. Mother and three daughters Marked psychomotor retardation, strabismus,
hypodontia and skeletal dysplasia
Not performed
t1:8 [18] 1972 Rubin Two brothers, sister, father and paternal uncle None Not performed
t1:9 [19] 1973 Jelinek et al. Distant and deceased relatives, paternal great aunt Epileptic seizures and strabismus Not performed
t1:10 [9] 1974 Cram and Fukuyama Child, his mother and his maternal grandfather Epileptic seizures Not performed
t1:11 [20] 1975 Hellgren Mother, sister and brother Macrocheilia, iris pigmented spots and hair anomalies Not performed
t1:12 [21] 1975 Griffiths and Payne Mother and father (first cousins) Ocular hypertelorism, nails and fingers anomalies Not performed
t1:13 [22] 1977 Schwartz et al. Nephew and maternal grandmother Epileptic seizures, retardation, macrocephaly, delayed closure anterior
fontanelle, leg length discrepancy, scoliosis and iridial heterochromia
Not performed
t1:14 [10] 1987 Patrizi et al. Mother and two sibs Neurological symptoms Not performed
t1:15 [23] 1990 Amon et al. Mother and daughter Ocular symptomatology Deletion of chromosome 15
t1:16 (peripheral lymphocytes and
fibroblasts)
t1:17 [24] 1991 Montagna et al. Mother and two sibs Mental and cerebellar signs, organic psychosis Normal (peripheral lymphocytes)
t1:18 [3] 1992 Vormittag et al. Mother and daughter Epileptic seizures, ophthalmologic abnormalities,
scoliosis and lordosis
Normal (peripheral lymphocytes)
t1:19 Tetraploidy in #2 (23%), #5 (11%),
#11 and #14 (6%), #18 and #21
(2%) (fibroblasts)
t1:20 [11] 1993 Zappella A pair of monozygotic and a pair of dizygotic twins Autism, delayed psychomotor development and microcephaly Normal (peripheral lymphocytes)
t1:21 2014 Ponti et al. Father and daughter None Normal (peripheral lymphocytes)
t1:22 Paternal trisomy 2 (fibroblasts)
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173 characterized by the distribution of hypopigmented streaks
174 along the Blaschko lines.
175 Conclusions
176 Our case remarks the critical role of a careful clinical in-
177 spection of all close family members. We therefore sug-
178 gest the importance of the of apparently innocent and
179 small hypopigmented lesions in order to highlight and
180 demonstrate the presence of a hereditary disorder of
181 pigmentation. Regarding the definition of this peculiar
182 disorder, it is known that the original name incontinen-
183 tia pigmenti achromians results from the features of the
184 peculiar depigmented changes corresponding to the nega-
185 tive of the morphologic changes characteristic of patients
186 with incontinentia pigmenti [1-3]. However, it is well
187 known that this definition is incorrect, because histo-
188 logically no incontinent melanin is seen in the dermis,
189 but only a decrease in the number of melanosomes. The
190 most appropriate term hypomelanosis of Ito, pigmentary
191 dysplasia and pigmentary mosaicism are synonyms of the
192 same cutaneous signs. The name Ito syndrome is errone-
193 ous as a generic definition of this sporadic condition, and,
194 in our opinion, should be reserved only to familial HMI
195 cases in which the phenotype and the common chromo-
196 somal aberrations are documented in at least two first
197 degree-relatives with a systemic involvement of several
198 organs or tissues.
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